The Victorian Comprehensive Cancer Centre

open menu button

MENU

 
 

The Board

The VCCC Board is comprised of the leaders of each member organisation and an independent chair (Professor Linda Kristjanson) and deputy chair (Professor Robert Thomas).  The Board provides strategic direction and oversight to the VCCC and is served by a range of subcommittees that draw together expertise from the members to help achieve the goals of the VCCC. The Executive Director of the VCCC is Professor Grant McArthur who reports to the Board. The Board is also served by the Company Secretary: Mr Craig Zanker.

Board Members

Professor Linda Kristjanson AO - Chairperson
BN, MN, PhD, FAIDC

Professor Kristjanson is Vice-Chancellor of Swinburne University of Technology. She has been a pioneer in the field of palliative care research – recognised in 2012 by the Bethlehem Griffith Research Foundation lifetime achievement award. During her academic career she has received competitive research funding from national bodies in Canada (National Cancer Institute of Canada), USA (NIH) and Australia (NHMRC) and has published more than 300 refereed publications. She is a Fellow of the Australian Institute of Company Directors and previously served on the National Health & Medical Research Council (2006-2009).

In 2002 Professor Kristjanson was named the Australian Telstra Business Woman of the Year in recognition of her entrepreneurial work in health and science. Professor Kristjanson was appointed the Chair of the Victorian Comprehensive Cancer Centre in 2016. In 2017 Professor Kristjanson was made an Officer of the Order of Australia in the 2017 Queen’s Birthday Honours list. She was recognised for her distinguished service to tertiary education through leadership and governance roles, strategic and innovative university reforms, and contributions to cancer research, palliative care and to women.   

Professor Kristjanson was appointed the Chair of the Victorian Comprehensive Cancer Centre in July 2016.

Professor Robert Thomas - Deputy Chairperson
MS MBBS FRACS FRCS       
                        

Professor Thomas is a Special Advisor on Health to the Victorian Government and University of Melbourne, and Chair of the Advisory Board of Cancer Australia. He is co-chair of the National Cancer Expert Reference Group ( NCERG) an AHMAC and Australian Government committee. He is Deputy Chair of the Victorian Comprehensive Cancer Centre. His current mission with NCERG is to achieve implementation of the Optimal Care Cancer pathways, a program of work agreed by all jurisdictions. These pathways, now backed by large linked datasets are set to guide provision of uniform care to all populations and reduce variation in outcomes and costs
As past Chair of the Victorian Cancer Agency and one of the original members of the Agency he worked with Government to provide new recurrent funding for cancer research in Victoria. He was instrumental in developing large scale collaborative cancer research programs across Institutions in Victoria.
Professor Thomas is passionate about cancer system reform, and as Chief Cancer Advisor to Government over the past 10 years has worked to provide all Victorians with the benefits of multidisciplinary care, appropriate psychosocial support for cancer patients and carers, and access to the best translational research.

Professor Thomas was appointed the Deputy Chair of the Victorian Comprehensive Cancer Centre in July 2016.

Adjunct Professor Dale Fisher
BB (BA), MBA, AFACHSE                                          

Dale Fisher is the Chief Executive of the Peter MacCallum Cancer Centre, Australia's only public hospital solely dedicated to cancer treatment, research and education and home to Australia's largest cancer research program. Dale led the relocation of Peter Mac's East Melbourne site to its new home in Parkville in 2016, as part of the $1.1 billion VCCC Project.

Prior to joining Peter Mac, Dale was Chief Executive of the Royal Women's Hospital for nine years.In recognition of her achievements in leadership and promoting excellence in women’s health to the Victorian community, Dale was inducted into the Victorian Honour Roll in 2011 as part of the centenary celebrations for International Women’s Day.

In October 2013, Dale’s many roles as a strategic and educational leader were again recognised when she was honoured as one of the Australian Financial Review’s 100 Women of Influence. While practising as a Registered Nurse, Dale pursued studies in business management and completed a Bachelor of Business (BA) at RMIT University and a Masters of Business (MBA) at Monash University.

Dale is a Board member of the Victorian Comprehensive Cancer Centre; the Committee for Melbourne and of St Michael’s Grammar School; and is an Associate Fellow of the Australian College of Health Service Executives. In March 2016 Dale was appointed as Adjunct Professor in the School of Public Health and Preventative Medicine, Monash University.

She has been a Director of the Company since 27 October 2009.

Professor Douglas Hilton
AO FAA FTSE FAHMS
                                                                    

Prof. Doug Hilton is the 6th Director of the Walter and Eliza Hall Institute, Head of the Department of Medical Biology in the Faculty of Medicine, Dentistry and Health Sciences at the University of Melbourne, and the immediate past President of the Association of Australian Medical Research Institutes (AAMRI).

He is best known for his discoveries in the area of cytokine signalling, his advocacy for health & medical research and for gender equity in science. The Hilton lab aims to understand which of the 30,000 genes are important in the production and function of blood cells, and how this information can be used to better prevent, diagnose and treat blood cell diseases such as leukaemia, arthritis and asthma. Prof. Hilton has been awarded numerous prizes for his research into how blood cells communicate and has led major collaborations with industry to translate his discoveries from the bench to the bedside.

He is an inventor of more than 20 patent families, most of which have been licensed, and is a co-founder of the biotechnology company MuriGen. He is an Officer of the Order of Australia, and a Fellow of the Australian Academy of Science, of Technological Sciences and Engineering, and of Health and Medical Sciences.

He has been a Director of the Company since 27 October 2009.

Professor Christine J. Kilpatrick
MBBS, MBA, MD, FRACP, FRACMA, FAICD. FAHMS, DMedSci (Hons)
                                       

Christine Kilpatrick commenced as Chief Executive, Melbourne Health in May 2017. Previous appointments include Chief Executive, The Royal Children’s Hospital from 2008 – 2017, Executive Director Medical Services, Melbourne Health and Executive Director Royal Melbourne Hospital, Melbourne Health.

Prior to these appointments she was a neurologist, specialising in epilepsy. Christine has held several external appointments including Chair Victorian Quality Council in Healthcare and Member of the Women’s and Children’s Health Board. She was awarded a Centenary medal in 2003 and in 2014 was included in the Victorian Honour Roll of Women.   

Christine has been a Director from 1 July 2010 through to 20 April 2017 and again from 1 May 2017.

Professor James McCluskey
BMedSc, MB BS MD UWA, FRACP, FRCPA, FAA, FAHMS

Professor James McCluskey has been the Deputy Vice-Chancellor Research at The University of Melbourne since 2011. He is also a Redmond Barry Distinguished Professor in Microbiology and Immunology, known for his research in basic and clinical immunology in the area of genetic control of specific immunity. He established the SA division of the Australian Bone Marrow Donor Registry and has consulted for the Australian Red Cross in the area of solid organ and haemopoeitic stem cell transplantation matching for more than 25 years.

He is a member of the board of directors of the Bionics Institute, Australian Friends of Asha Slums, Walter & Eliza Hall Institute of Medical Research, Nossal Institute Ltd and UoM Commercial. He has previously been a director of the Florey Institute of Neuroscience and Mental Health, St Vincent’s Institute, the Burnet Institute and several CRCs. He led the development of the Peter Doherty Institute for Infection and Immunity, a joint venture between The University of Melbourne and Melbourne Health. He recently led the team that created the Atlantic Fellows for Social Equity program primarily for development of indigenous leadership.

He has been a Director of the Company since 1st September 2015.

Dr Sue Matthews
RN, BA, MHScN, Wharton Fellow, DPH                                  

Sue is an experienced health service leader with more than 20 years of senior operational and strategic leadership in hospitals, community care and government. She is currently CEO of the Royal Women’s Hospital in Melbourne, Australia. Sue is a Director of the Victorian Comprehensive Cancer Centre Board and the Victorian Healthcare Association. She holds an R.N Diploma, Bachelor of Arts Health Studies, Masters of Health Science Nursing, and a Doctorate in Public Health. She is also a Fellow of the Wharton School of Business in Philadelphia and a Graduate of the Australian Institute of Company Directors. She is appointed as Adjunct Professor at Charles Sturt University, Trent University, Brock University and Clinical Associate Professor at McMaster University. Sue has won numerous awards including One of Canada’s Top 100 Most Powerful Women and the Canadian Nurses Association Centennial Award and most recently the Royal Women’s Hospital was awarded the Victorian Premier’s Health Service of the Year.

She has been a Director of the Company since 3 April 2014.       

Professor Kathryn North AM
BSc(Med) MBBS MD FRACP                                            

Professor Kathryn North AM is Director of the Murdoch Children’s Research Institute and the David Danks Professor of Child Health Research at the University of Melbourne. Professor North is trained as a paediatric physician, neurologist and clinical geneticist and in 1994, was awarded a doctorate for research in neurogenetics. She completed a postdoctoral fellowship in the Harvard Genetics Program.

Professor North has received a number of awards for her research including the GSK Australia Award for Research Excellence (2011), the Ramaciotti Medal for Excellence in Biomedical Research (2012) and the Member of the Order of Australia (AM) for service to medicine in the field of neuromuscular and neurogenetics research (2012). In 2012, Professor North was appointed Chair of the National Health and Medical Research Council Research Committee and in 2014 was appointed as a Foundation fellow of the Australian Academy of Health and Medical Science and Vice Chair of the Global Alliance for Genomics and Health. She chairs the International Advisory Board of the Great Ormond Street Institute of Child Health (UK) and is a Member of the Peter MacCallum Cancer Centre Research Advisory Board.

She has been a Director of the Company since 1st July 2015.       

Ms Sue Shilbury
BAppSc (Phty) MBA Member AICD

Sue Shilbury joined Austin Health as CEO in early 2017, following a three-decade career in the New South Wales public health sector. Sue's roles have included General Manager of North Shore Ryde Health Service, in which she oversaw the delivery of New South Wales Health's largest capital works program, the $1.3 billion redevelopment of Royal North Shore Hospital.

Sue has also held roles as General Manager of the Central Hospital Network (South Eastern Sydney and Illawarra Health District); Director of the Division of Critical Care and Surgery at St George Hospital; and Director of Clinical Services at the Royal Hospital for Women.

Sue formerly held a non-executive Director position on the Board of NSW Family Planning.

Sue has been a Director of the Company since 30 January 2017.

Mr John Stanway
BEc, Grad Dip IR, FAICD

John Stanway is the Chief Executive Officer (CEO). As well as being a Director of the Victorian Comprehensive Cancer Centre (VCCC) Board, the Royal Children’s Hospital Foundation (RCHF) Board and the Murdoch Children’s Research Institute (MCRI) Board, John is also a member of the Melbourne Children’s Council, Melbourne Genomics Alliance, Parkville Precinct Leadership Group, Melbourne Academic Centre for Health (MACH) and National Collaborative Network for Child Health Informatics. Previously, John managed Monash Medical Centre, was Chief Executive of the Transport Accident Commission and held various senior management roles at General Motors Holden. John was President of the Victorian Hospitals Industrial Association and Chairman for 10 years. John has a double major in Economics and a Graduate Diploma in Industrial Relations and is a Fellow of the Australian Institute of Company Directors.

John has been a Director of the Company since 21 April 2017.